HK1036805A1 - Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders - Google Patents

Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders

Info

Publication number
HK1036805A1
HK1036805A1 HK01105568.0A HK01105568A HK1036805A1 HK 1036805 A1 HK1036805 A1 HK 1036805A1 HK 01105568 A HK01105568 A HK 01105568A HK 1036805 A1 HK1036805 A1 HK 1036805A1
Authority
HK
Hong Kong
Prior art keywords
chemokine receptor
immune disorders
peptides
receptor domain
hiv treatment
Prior art date
Application number
HK01105568.0A
Other languages
English (en)
Inventor
Chang Yi Wang
Original Assignee
United Biomedical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United Biomedical Inc filed Critical United Biomedical Inc
Publication of HK1036805A1 publication Critical patent/HK1036805A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK01105568.0A 1998-06-20 2001-08-10 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders HK1036805A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/100,409 US6090388A (en) 1998-06-20 1998-06-20 Peptide composition for prevention and treatment of HIV infection and immune disorders
PCT/US1999/014030 WO1999067294A1 (en) 1998-06-20 1999-06-21 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders

Publications (1)

Publication Number Publication Date
HK1036805A1 true HK1036805A1 (en) 2002-01-18

Family

ID=22279612

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01105568.0A HK1036805A1 (en) 1998-06-20 2001-08-10 Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders

Country Status (15)

Country Link
US (1) US6090388A (zh)
EP (1) EP1098910B1 (zh)
JP (1) JP4216473B2 (zh)
CN (1) CN1207306C (zh)
AT (1) ATE447585T1 (zh)
AU (1) AU766955B2 (zh)
BR (1) BRPI9912175B1 (zh)
CA (1) CA2330235C (zh)
DE (1) DE69941625D1 (zh)
DK (1) DK1098910T3 (zh)
ES (1) ES2336393T3 (zh)
HK (1) HK1036805A1 (zh)
TW (1) TWI227242B (zh)
WO (1) WO1999067294A1 (zh)
ZA (1) ZA200006385B (zh)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417324B1 (en) * 2000-04-21 2002-07-09 Tripep Ab Synthetic peptides that bind to the hepatitis B virus core and e antigens
US6660842B1 (en) 1994-04-28 2003-12-09 Tripep Ab Ligand/receptor specificity exchangers that redirect antibodies to receptors on a pathogen
US6040137A (en) * 1995-04-27 2000-03-21 Tripep Ab Antigen/antibody specification exchanger
US6933366B2 (en) * 1996-12-27 2005-08-23 Tripep Ab Specificity exchangers that redirect antibodies to bacterial adhesion receptors
US20030054012A1 (en) * 2000-05-12 2003-03-20 Fitzgerald David J. Pseudomonas exotoxin a-like chimeric immunogens for eliciting a secretory iga-mediated immune response
CA2295971C (en) * 1997-07-11 2011-02-08 THE GOVERNMENT OF THE UNITED STATES, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Pseudomonas exotoxin a-like chimeric immunogens
US7314632B1 (en) * 1997-07-11 2008-01-01 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pseudomonas exotoxin A-like chimeric immunogens
TWI229679B (en) * 1998-06-20 2005-03-21 United Biomedical Inc Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
EP1141313A2 (en) * 1998-12-31 2001-10-10 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US7935805B1 (en) * 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
WO2000039303A2 (en) 1998-12-31 2000-07-06 Chiron Corporation Modified hiv env polypeptides
WO2002004499A1 (en) * 2000-07-12 2002-01-17 Gryphon Therapeutics, Inc. Chemokine receptor modulators, production and use
US7118737B2 (en) 2000-09-08 2006-10-10 Amylin Pharmaceuticals, Inc. Polymer-modified synthetic proteins
AU2001273388B2 (en) * 2000-09-08 2005-01-13 Gryphon Therapeutics, Inc. "Pseudo"-native chemical ligation
CA2438515A1 (en) * 2001-02-15 2002-08-22 The Government Of The United States Of America Methods and compositions for inhibiting hiv-coreceptor interactions
US20040077835A1 (en) * 2001-07-12 2004-04-22 Robin Offord Chemokine receptor modulators, production and use
WO2003020876A2 (en) * 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
US20060147477A1 (en) * 2002-06-11 2006-07-06 Glaxo Group Limited Immunogenic compositions
AU2003251053B2 (en) * 2002-08-13 2009-11-19 Haptogen Ltd Methods for the treatment of an infectious bacterial disease with an anti-lactone or lactone derived signal molecules antibody
EP2230249A3 (en) * 2003-02-06 2010-12-22 ChronTech Pharma AB Antigen/antibody or ligand/receptor glycosylated specificity exchangers
US7335359B2 (en) * 2003-02-06 2008-02-26 Tripep Ab Glycosylated specificity exchangers
GB0407008D0 (en) * 2004-03-27 2004-04-28 Haptogen Ltd Methods for inducing rapid cell death (autolysis) in infectious bacteria
GB0410958D0 (en) * 2004-05-15 2004-06-16 Haptogen Ltd Methods for reducing biofilm formation in infectious bacteria
US9340601B2 (en) * 2007-03-01 2016-05-17 The Board Of Trustees Of The Leland Stanford Junior University Splice variants of the EGF receptor
US20090092631A1 (en) * 2007-03-26 2009-04-09 Tripep Ab Glycosylated specificity exchangers that induce an antibody dependent cellular cytotoxicity (adcc) response
US8501907B2 (en) 2007-08-10 2013-08-06 Janssen Biotech, Inc. Immunoglobulin cleavage fragments as disease indicators and compositions for detecting and binding such
ITPA20080007A1 (it) * 2008-03-19 2009-09-20 Angela Bonura Fattore anti - lps da parietaria judaica e suoi metodi di utilizzo.
TW201029663A (en) 2008-11-12 2010-08-16 Theraclone Sciences Inc Human M2e peptide immunogens
US20110305670A1 (en) * 2010-06-10 2011-12-15 President And Fellows Of Harvard College Nucleic acid encoding fusion polypeptides that prevent or inhibit hiv infection
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
MX2013005646A (es) * 2010-11-19 2013-08-01 Janssen Biotech Inc Composiciones de vacuna de fragmentos de clivaje de la inmunoglobulina.
CN102380094B (zh) * 2011-10-11 2013-08-07 中国科学院微生物研究所 特异多肽在制备狂犬病疫苗中的应用
US11180555B2 (en) 2014-09-16 2021-11-23 Ubi Us Holdings, Llc. Antibodies directed against CD4 for the treatment and functional cure of HIV
EP3497133A4 (en) 2016-08-13 2020-03-25 UBI IP Holdings TREATMENT AND DELAYED VIROLOGICAL REMISSION OF HIV INFECTIONS BY ANTIBODIES AGAINST CD4 IN HAIR-STABILIZED PATIENTS
CN108640977A (zh) * 2018-06-18 2018-10-12 上海大学 特异性结合HIV上包膜糖蛋白gp120的多肽及其应用
CN113318225B (zh) * 2020-02-28 2024-01-19 无锡派列博生物医药科技有限公司 肿瘤免疫增强剂及其制法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0768273B2 (ja) * 1988-12-02 1995-07-26 カルピス食品工業株式会社 抗ｈｉｖペプチド
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
JP3795914B2 (ja) * 1993-04-27 2006-07-12 ユナイテッド・バイオメディカル・インコーポレイテッド ワクチン用免疫原性ｌｈｒｈペプチド構築体および合成普遍免疫刺激器
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
EP0725838A4 (en) * 1993-10-26 1997-02-26 United Biomedical Inc STRUCTURED SYNTHETIC ANTIGAN BANKS AS DIAGNOSTICS, VACCINE AND THERAPEUTIC AGENTS
CN1146772A (zh) * 1994-03-28 1997-04-02 美国联合生物医学公司 用于治疗过敏反应的合成肽免疫原
CA2256306C (en) * 1996-06-03 2011-03-29 United Biomedical, Inc. Antibodies against a complex of cd4 and a chemokine receptor domain, and their use against hiv infections

Also Published As

Publication number Publication date
BRPI9912175B8 (zh) 2021-07-06
JP4216473B2 (ja) 2009-01-28
JP2002518523A (ja) 2002-06-25
BRPI9912175A (pt) 2001-04-10
AU4704899A (en) 2000-01-10
ATE447585T1 (de) 2009-11-15
ES2336393T3 (es) 2010-04-12
EP1098910B1 (en) 2009-11-04
DE69941625D1 (de) 2009-12-17
US6090388A (en) 2000-07-18
EP1098910A4 (en) 2005-02-02
EP1098910A1 (en) 2001-05-16
CN1303394A (zh) 2001-07-11
TWI227242B (en) 2005-02-01
BRPI9912175B1 (pt) 2019-08-27
CA2330235C (en) 2008-08-12
CA2330235A1 (en) 1999-12-29
CN1207306C (zh) 2005-06-22
ZA200006385B (en) 2001-10-11
WO1999067294A1 (en) 1999-12-29
AU766955B2 (en) 2003-10-30
DK1098910T3 (da) 2010-02-01

Similar Documents

Publication Publication Date Title
HK1036805A1 (en) Antigenic complex comprising immunostimulatory peptide, cd4, and chemokine receptor domain for hiv treatment and immune disorders
HK1036804A1 (en) Peptide composition as immunogen for the treatment of allergy
CA2135833C (en) Antigen carbohydrate compounds and their use in immunotherapy
Fayolle et al. Delivery of multiple epitopes by recombinant detoxified adenylate cyclase of Bordetella pertussis induces protective antiviral immunity
WO2006037421A3 (en) Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes
EP0651818A4 (en) IMMUNOGENIC PEPTIDES, ANTIBODIES AND USES THEREOF IN CONNECTION WITH THE BINDING OF THE CD4 MOLECULE RECEPTOR.
EP1450857A4 (en) NEUTRALIZATION ANTIBODIES WITH SUBSTANTIALLY CROSSED HIV VIRUS ACTIVITY SELECTED USING ENV-CD4 CO-RECEPTOR COMPLEXES
CA2336743A1 (en) Antigenic peptides derived from telomerase
EP0789574A4 (en) METHOD AND DEVICES FOR IMMUNIZING A HOST AGAINST TUMOR ASSOCIATED ANTIGENS BY ADMINISTRATING NAKED POLYNUCLEOTIDES CODING TUMOR ASSOCIATED ANTIGEN PEPTIDES
IL125590A (en) Peptide immunogens, process for their preparation and use thereof as vaccines against allergies
DE69840383D1 (de) Ctl epitope des epstein-barr virus
TR200100936T2 (tr) Terapötik aşılama
WO2003045128A3 (en) SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
CA2248667A1 (en) Hla-a2.1 binding peptides and their uses
EP1461079A4 (en) HIV ENVELOPE GLYCOPROTEIN MUTANTS AND USES THEREOF
RU2009101191A (ru) Sparc-производные антигенные пептиды отторжения опухоли и лекарственные средства, содержащие их
CN113164445A (zh) Tlr1/2激动剂地普罗考姆的佐剂作用协同增效检查点抑制性抗体以消除疾病
CA2242878A1 (en) Induction of immune response against desired determinants
RU2008137968A (ru) Иммуномодулирующие и противоопухолевые пептиды
Pouniotis et al. Penetratin tandemly linked to a CTL peptide induces anti‐tumour T‐cell responses via a cross‐presentation pathway
CA2128407C (en) Synthetic peptides for a rubella vaccine
Hosmalin et al. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1.
Iglesias et al. Influence of aluminum-based adjuvant on the immune response to multiantigenic formulation
Yu et al. Peptide‐antibody conjugates for tumour therapy: A MHC‐class‐II‐restricted tetanus toxin peptide coupled to an anti‐IG light chain antibody can induce cytotoxic lysis of a human B‐cell lymphoma by specific CD4 T cells
CN113906046A (zh) 具有包含经修饰半胱氨酸的氧化还原酶基序的免疫原性肽

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20190620